Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: A comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy

Clinical Endocrinology

Volumn 83, Issue 1, 2015, Pages 28-35

  Björnsdottir, Sigridur ^a   Øksnes, Marianne ^b,c   Isaksson, Magnus ^d   Methlie, Paal ^b   Nilsen, Roy M ^c   Hustad, Steinar ^b   Kämpe, Olle ^d   Hulting, Anna Lena ^a   Husebye, Eystein S ^b,c   Løvås, Kristian ^b,c   Nyström, Thomas ^e   Bensing, Sophie ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d UPPSALA UNIVERSITY   (Sweden)

^e STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTISONE; GLUCOSE; GROWTH HORMONE; HORMONE; HYDROCORTISONE; INSULIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; TRIACYLGLYCEROL; GLUCOCORTICOID;

ABSENCE OF SIDE EFFECTS; ADDISON DISEASE; ADULT; ARTICLE; BODY SURFACE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTINUOUS SUBCUTANEOUS HYDROCORTISONE INFUSION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSSOVER PROCEDURE; DRUG DOSE TITRATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN INFUSION; INSULIN PUMP; INSULIN SENSITIVITY; MALE; MULTICENTER STUDY; NORWAY; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SWEDEN; TIME TO TREATMENT; TREATMENT RESPONSE; AGED; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; GLUCOSE CLAMP TECHNIQUE; HORMONE SUBSTITUTION; INSULIN RESISTANCE; MIDDLE AGED; PROCEDURES; SUBCUTANEOUS DRUG ADMINISTRATION; YOUNG ADULT;

ADDISON DISEASE; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; FEMALE; GLUCOCORTICOIDS; GLUCOSE CLAMP TECHNIQUE; HORMONE REPLACEMENT THERAPY; HUMANS; HYDROCORTISONE; INFUSIONS, SUBCUTANEOUS; INSULIN RESISTANCE; MALE; MIDDLE AGED; NORWAY; SWEDEN; YOUNG ADULT;

EID: 84932194005     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12670     Document Type: Article

References (35)

1. Bensing, S., Brandt, L., Tabaroj, F., et al,. (2008) Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clinical Endocrinology, 69, 697-704.
2. Giordano, R., Marzotti, S., Balbo, M., et al,. (2009) Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement. Journal of Endocrinological Investigation, 32, 917-923.
3. Bjornsdottir, S., Sundstrom, A., Ludvigsson, J.F., et al,. (2013) Drug prescription patterns in patients with Addison's disease: a Swedish population-based cohort study. The Journal of Clinical Endocrinology and Metabolism, 98, 2009-2018.
4. Dallman, M.F., Akana, S.F., Bhatnagar, S., et al,. (2000) Bottomed out: metabolic significance of the circadian trough in glucocorticoid concentrations. International Journal of Obesity and Related Metabolic Disorders, 24 (Suppl 2), S40-S46.
5. Plat, L., Leproult, R., L'Hermite-Baleriaux, M., et al,. (1999) Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. The Journal of Clinical Endocrinology and Metabolism, 84, 3082-3092.
6. Meyer, G., Hackemann, A., Reusch, J., et al,. (2012) Nocturnal hypoglycemia identified by a continuous glucose monitoring system in patients with primary adrenal insufficiency (Addison's disease). Diabetes Technology & Therapeutics, 14, 386-388.
7. Erichsen, M.M., Lovas, K., Skinningsrud, B., et al,. (2009) Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian Registry. The Journal of Clinical Endocrinology and Metabolism, 94, 4882-4890.
8. Mah, P.M., Jenkins, R.C., Rostami-Hodjegan, A., et al,. (2004) Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clinical Endocrinology, 61, 367-375.
9. Dinneen, S., Alzaid, A., Miles, J., et al,. (1993) Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans. The Journal of Clinical Investigation, 92, 2283-2290.
10. Morris, C.J., Aeschbach, D., &, Scheer, F.A., (2012) Circadian system, sleep and endocrinology. Molecular and Cellular Endocrinology, 349, 91-104.
11. Giustina, A., &, Veldhuis, J.D., (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocrine Reviews, 19, 717-797.
12. Mazziotti, G., &, Giustina, A., (2013) Glucocorticoids and the regulation of growth hormone secretion. Nature Reviews. Endocrinology, 9, 265-276.
13. Wajchenberg, B.L., Liberman, B., Giannella Neto, D., et al,. (1996) Growth hormone axis in cushing's syndrome. Hormone Research, 45, 99-107.
14. Merza, Z., Rostami-Hodjegan, A., Memmott, A., et al,. (2006) Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia. Clinical Endocrinology, 65, 45-50.
15. Lovas, K., &, Husebye, E.S., (2007) Continuous subcutaneous hydrocortisone infusion in Addison's disease. European Journal of Endocrinology, 157, 109-112.
16. Oksnes, M., Bjornsdottir, S., Isaksson, M., et al,. (2014) Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of Addison's disease: a randomized clinical trial. The Journal of Clinical Endocrinology and Metabolism, 99, 1665-1674.
17. DeFronzo, R.A., Tobin, J.D., &, Andres, R., (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology, 237, E214-E223.
18. Knutsson, U., Dahlgren, J., Marcus, C., et al,. (1997) Circadian cortisol rhythms in healthy boys and girls: relationship with age, growth, body composition, and pubertal development. The Journal of Clinical Endocrinology and Metabolism, 82, 536-540.
19. Gagliardi, L., Nenke, M.A., Thynne, T.R., et al,. (2014) Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomised, placebo-controlled clinical trial. The Journal of Clinical Endocrinology and Metabolism, 99, 4149-4157.
20. Spiegel, K., Leproult, R., &, Van Cauter, E., (1999) Impact of sleep debt on metabolic and endocrine function. Lancet, 354, 1435-1439.
21. Johannsson, G., Nilsson, A.G., Bergthorsdottir, R., et al,. (2012) Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. The Journal of Clinical Endocrinology and Metabolism, 97, 473-481.
22. Shea, S.A., Hilton, M.F., Orlova, C., et al,. (2005) Independent circadian and sleep/wake regulation of adipokines and glucose in humans. The Journal of Clinical Endocrinology and Metabolism, 90, 2537-2544.
23. Al-Shoumer, K.A., Ali, K., Anyaoku, V., et al,. (1996) Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism. Clinical Endocrinology, 45, 171-178.
24. Elbelt, U., Hahner, S., &, Allolio, B., (2009) Altered insulin requirement in patients with type 1 diabetes and primary adrenal insufficiency receiving standard glucocorticoid replacement therapy. European Journal of Endocrinology, 160, 919-924.
25. Wurtman, R.J., (2002) Stress and the adrenocortical control of epinephrine synthesis. Metabolism, 51, 11-14.
26. Erichsen, M.M., Lovas, K., Fougner, K.J., et al,. (2009) Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. European Journal of Endocrinology, 160, 233-237.
27. Klement, J., Hubold, C., Cords, H., et al,. (2010) High-calorie glucose-rich food attenuates neuroglycopenic symptoms in patients with Addison's disease. The Journal of Clinical Endocrinology and Metabolism, 95, 522-528.
28. Klement, J., Hubold, C., Hallschmid, M., et al,. (2009) Effects of glucose infusion on neuroendocrine and cognitive parameters in Addison disease. Metabolism, 58, 1825-1831.
29. Van Cauter, E., Shapiro, E.T., Tillil, H., et al,. (1992) Circadian modulation of glucose and insulin responses to meals: relationship to cortisol rhythm. American Journal of Physiology, 262, E467-E475.
30. Danilowicz, K., Bruno, O.D., Manavela, M., et al,. (2008) Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study. Pituitary, 11, 279-285.
31. Tam, C.S., Xie, W., Johnson, W.D., et al,. (2012) Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care, 35, 1605-1610.
32. McConnell, E.M., Bell, P.M., Ennis, C., et al,. (2002) Effects of low-dose oral hydrocortisone replacement versus short-term reproduction of physiological serum cortisol concentrations on insulin action in adult-onset hypopituitarism. Clinical Endocrinology, 56, 195-201.
33. Suliman, A.M., Freaney, R., Smith, T.P., et al,. (2003) The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency. Clinical Endocrinology, 59, 380-387.
34. Giustina, A., Bresciani, E., Bossoni, S., et al,. (1994) Reciprocal relationship between the level of circulating cortisol and growth hormone secretion in response to growth hormone-releasing hormone in man: studies in patients with adrenal insufficiency. The Journal of Clinical Endocrinology and Metabolism, 79, 1266-1272.
35. Barkan, A.L., DeMott-Friberg, R., &, Samuels, M.H., (2000) Growth hormone (GH) secretion in primary adrenal insufficiency: effects of cortisol withdrawal and patterned replacement on GH pulsatility and circadian rhythmicity. Pituitary, 3, 175-179.